title: The importance and challenge of pediatric trials of hemophilia drugs.
authors.affiliation: 1] European Medicines Agency, London, UK. [2] Paul-Ehrlich Institute, Langen, Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Mentzer
authors.affiliation: European Medicines Agency, London, UK.
authors.forename: Emilie
authors.initials: E
authors.lastname: Desfontaine
authors.affiliation: European Medicines Agency, London, UK.
authors.forename: Paolo A
authors.initials: PA
authors.lastname: Tomasi
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans